AAMU
SLXP

Amundi Asset Management US’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Amundi Asset Management US’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-36,771
Closed -$6.35M – 663
2015
Q1 		$6.35M Sell
36,771
-131,113
-78% -$19.2M 0.02% 419
2014
Q4 		$19.3M Sell
167,884
-206,336
-55% -$25M 0.07% 270
2014
Q3 		$58.5M Sell
374,220
-43,035
-10% -$6.24M 0.22% 130
2014
Q2 		$51.5M Sell
417,255
-33,177
-7% -$3.67M 0.2% 143
2014
Q1 		$46.7M Buy
450,432
+39,993
+10% +$4.09M 0.18% 158
2013
Q4 		$36.9M Sell
410,439
-42,494
-9% -$3.39M 0.14% 177
2013
Q3 		$30.3M Buy
452,933
+81,833
+22% +$5.64M 0.12% 191
2013
Q2 		$24.5M Buy
+371,100
New +$21.2M 0.1% 229

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Amundi Asset Management US's SLXP Position: Q2 2015 in Review

Amundi Asset Management US sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 36,771 shares — an estimated $6.35M sold.

Amundi Asset Management US first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $58.5M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Amundi Asset Management US reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Amundi Asset Management US sold 36,771 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $6.35M.
  • Amundi Asset Management US first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Amundi Asset Management US's SALIX PHARMACEUTICALS LTD DEL position peaked at $58.5M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Amundi Asset Management US's 13F filing for Q2 2015, filed 6 Aug 2015.